These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31882454)

  • 1. From Genotype to Phenotype: Content and Activities of Cytochromes P450 2A6 in Human Liver In Vitro and Predicted In Vivo.
    Fang Y; Wang T; Guo YY; Zhang HF; Wen Q; Xing YR; Gao N; Qiao HL
    J Pharmacol Exp Ther; 2020 Mar; 372(3):320-330. PubMed ID: 31882454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.
    Tanner JA; Prasad B; Claw KG; Stapleton P; Chaudhry A; Schuetz EG; Thummel KE; Tyndale RF
    J Pharmacol Exp Ther; 2017 Jan; 360(1):129-139. PubMed ID: 27815364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes.
    Murai K; Yamazaki H; Nakagawa K; Kawai R; Kamataki T
    Xenobiotica; 2009 Nov; 39(11):795-802. PubMed ID: 19845430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
    Tanner JA; Zhu AZ; Claw KG; Prasad B; Korchina V; Hu J; Doddapaneni H; Muzny DM; Schuetz EG; Lerman C; Thummel KE; Scherer SE; Tyndale RF
    Pharmacogenet Genomics; 2018 Jan; 28(1):7-16. PubMed ID: 29232328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
    Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
    Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
    Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
    Pearce R; Greenway D; Parkinson A
    Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians.
    Inoue K; Yamazaki H; Shimada T
    Arch Toxicol; 2000 Jan; 73(10-11):532-9. PubMed ID: 10663384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine.
    Le Gal A; Dréano Y; Lucas D; Berthou F
    Toxicol Lett; 2003 Sep; 144(1):77-91. PubMed ID: 12919726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.
    Miyazawa M; Gyoubu K
    Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
    Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans.
    Camus AM; Geneste O; Honkakoski P; Béréziat JC; Henderson CJ; Wolf CR; Bartsch H; Lang MA
    Mol Carcinog; 1993; 7(4):268-75. PubMed ID: 8352885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).
    Kiyotani K; Yamazaki H; Fujieda M; Iwano S; Matsumura K; Satarug S; Ujjin P; Shimada T; Guengerich FP; Parkinson A; Honda G; Nakagawa K; Ishizaki T; Kamataki T
    Pharmacogenetics; 2003 Nov; 13(11):689-95. PubMed ID: 14583682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of (+)- and (-)-menthols by CYP2A6 in human liver microsomes.
    Miyazawa M; Marumoto S; Takahashi T; Nakahashi H; Haigou R; Nakanishi K
    J Oleo Sci; 2011; 60(3):127-32. PubMed ID: 21343660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.
    Ueng YF; Chen CC; Chung YT; Liu TY; Chang YP; Lo WS; Murayama N; Yamazaki H; Souček P; Chau GY; Chi CW; Chen RM; Li DT
    Br J Pharmacol; 2011 Jul; 163(6):1250-62. PubMed ID: 21418183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP2A6 genetic polymorphism on the metabolic conversion of tegafur to 5-fluorouracil and its enantioselectivity.
    Yamamiya I; Yoshisue K; Ishii Y; Yamada H; Chiba M
    Drug Metab Dispos; 2014 Sep; 42(9):1485-92. PubMed ID: 25002745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolic characteristics of cytochrome P-450 2A6 in Chinese liver microsomes.
    Xia XY; Peng RX; Yu JP; Wang H; Wang J
    Acta Pharmacol Sin; 2002 May; 23(5):471-6. PubMed ID: 11978200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.